230 related articles for article (PubMed ID: 10079806)
21. Photopheresis. Therapeutic potential in preventing restenosis after percutaneous transluminal coronary angioplasty.
Bisaccia E; Palangio M; Gonzalez J; Klainer AS; Banas JS
Am J Cardiovasc Drugs; 2003; 3(1):43-51. PubMed ID: 14727945
[TBL] [Abstract][Full Text] [Related]
22. Extracorporeal photopheresis: clinical use so far.
Sanford KW; Balogun RA
J Clin Apher; 2012; 27(3):126-31. PubMed ID: 22467383
[TBL] [Abstract][Full Text] [Related]
23. ECP versus PUVA for the treatment of cutaneous T-cell lymphoma.
Geskin L
Skin Therapy Lett; 2007 Jun; 12(5):1-4. PubMed ID: 17609808
[TBL] [Abstract][Full Text] [Related]
24. [Extracorporeal photopheresis].
Prinz B; Plewig G
Hautarzt; 1994 Nov; 45(11):746-50. PubMed ID: 7822197
[TBL] [Abstract][Full Text] [Related]
25. Extracorporeal photopheresis for paediatric patients experiencing graft-versus-host disease (GVHD).
Rutella S; Valentini CG; Ceccarelli S; Romano MT; Brescia LP; Milano GM; Locatelli F
Transfus Apher Sci; 2014 Jun; 50(3):340-8. PubMed ID: 24780391
[TBL] [Abstract][Full Text] [Related]
26. Clinical and mechanistic aspects of photopheresis.
van Iperen HP; Beijersbergen van Henegouwen GM
J Photochem Photobiol B; 1997 Jun; 39(2):99-109. PubMed ID: 9225456
[TBL] [Abstract][Full Text] [Related]
27. The treatment of cutaneous T-cell lymphoma with photopheresis.
Zic JA
Dermatol Ther; 2003; 16(4):337-46. PubMed ID: 14686977
[TBL] [Abstract][Full Text] [Related]
28. Mode of action, indications and recommendations on extracorporeal photopheresis (ECP).
Cho A; Paulitschke V; Knobler R
J Dtsch Dermatol Ges; 2023 Nov; 21(11):1369-1380. PubMed ID: 37723908
[TBL] [Abstract][Full Text] [Related]
29. [Documented effect of extra corporeal photopheresis on T-cell mediated diseases].
Kofoed K; Schiødt I; Gniadecki R
Ugeskr Laeger; 2011 Jun; 173(26):1869-74. PubMed ID: 21712008
[TBL] [Abstract][Full Text] [Related]
30. [Apheresis in dermatologic diseases].
Strangi RM; D'Ascenzo G; Bilenchi R; Trovato E; Sansica P; Gorgoglione V
G Ital Nefrol; 2012; 29 Suppl 54():S119-24. PubMed ID: 22388842
[TBL] [Abstract][Full Text] [Related]
31. Modification of extracorporeal photopheresis technology with porphyrin precursors. Comparison between 8-methoxypsoralen and hexaminolevulinate in killing human T-cell lymphoma cell lines in vitro.
Cunderlíková B; Vasovič V; Randeberg LL; Christensen E; Warloe T; Nesland JM; Peng Q
Biochim Biophys Acta; 2014 Sep; 1840(9):2702-8. PubMed ID: 24915603
[TBL] [Abstract][Full Text] [Related]
32. Photopheresis in cutaneous T-cell lymphoma: five-year experience.
Crovetti G; Carabelli A; Berti E; Guizzardi M; Fossati S; De Filippo C; Bertani E
Int J Artif Organs; 2000 Jan; 23(1):55-62. PubMed ID: 12118838
[TBL] [Abstract][Full Text] [Related]
33. Extracorporeal photoimmunotherapy-photopheresis.
Dani T; Knobler R
Front Biosci (Landmark Ed); 2009 Jan; 14(12):4769-77. PubMed ID: 19273388
[TBL] [Abstract][Full Text] [Related]
34. Extracorporeal photopheresis: a review.
Oliven A; Shechter Y
Blood Rev; 2001 Jun; 15(2):103-8. PubMed ID: 11409910
[TBL] [Abstract][Full Text] [Related]
35. A method for the quantification of 8-methoxypsoralen by mass spectrometry for offline extracorporeal photopheresis.
Hähnel V; Dormann F; Nitsopoulos A; Friedle A; Ahrens N
Photochem Photobiol Sci; 2017 Feb; 16(2):193-200. PubMed ID: 27976780
[TBL] [Abstract][Full Text] [Related]
36. Current clinical applications of extracorporeal photochemotherapy.
Capuano M; Sommese L; Pignalosa O; Parente D; Fabbricini R; Nicoletti GF; De Pascale MR; Schiano C; Napoli C
Ther Apher Dial; 2015 Apr; 19(2):103-10. PubMed ID: 25363837
[TBL] [Abstract][Full Text] [Related]
37. A standardized methodical approach to characterize the influence of key parameters on the in vitro efficacy of extracorporeal photopheresis.
Laulhé M; Lefebvre S; Le Broc-Ryckewaert D; Pierre M; Ferry A; Delorme B
PLoS One; 2019; 14(3):e0212835. PubMed ID: 30822323
[TBL] [Abstract][Full Text] [Related]
38. [Update on extracorporeal photopheresis].
Just U; Knobler R
Hautarzt; 2015 Nov; 66(11):804-9. PubMed ID: 26431837
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous T-cell lymphoma and cutaneous graft-versus-host disease. Two indications for photopheresis in dermatology.
Girardi M; Heald PW
Dermatol Clin; 2000 Jul; 18(3):417-23, viii. PubMed ID: 10943537
[TBL] [Abstract][Full Text] [Related]
40. Real-world use of extracorporeal photopheresis for patients with cutaneous T-cell lymphoma in the United States: 2010-2015.
Ling YL; Huang X; Mitri G; Lovelace B; Pham A; Knobler R; Li X; Gao X
J Dermatolog Treat; 2020 Feb; 31(1):91-98. PubMed ID: 30892982
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
